Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanyou Yang

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Nuclear Medicine and Biology|March 4, 2019
A radiopharmaceutical [<sup>89</sup>Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivoYu Tang, Yingjiang Hu, Weihao Liu, et al.
Journal of Environmental Radioactivity|March 31, 2019
Sorption of selenite on Tamusu clay in simulated groundwater with high salinity under aerobic/anaerobic conditionsHanyi He, Jun Liu, Yang Dong, et al.
Theranostics|December 8, 2025
Emergence of a barium metal-organic framework for mitigating off-target effects of alpha radionuclide therapyLong Qiu, Jie Lyu, Yuqi Guo, et al.
Inorganic Chemistry|July 1, 2026
Molecular Insights into the Extraction and Stripping Mechanisms of UO<sub>2</sub><sup>2+</sup> and Th<sup>4+</sup> by the Externally α-Irradiated Tri-<i>iso</i>-pentyl PyrophosphateShilong Shi, Yaoshuang Wan, Guofeng Qu, et al.
Bioorganic & Medicinal Chemistry|November 8, 2023
Biocompatible conjugated polymer nanoparticles labeled with <sup>225</sup>Ac for tumor endoradiotherapyXijian Chen, Ranxi Liang, Weihao Liu, et al.
Molecular Pharmaceutics|August 20, 2025
Multivalent <sup>211</sup>At-Radiolabeled Fibroblast Activation Protein Inhibitors for Targeted Alpha-Therapy of GliomaTianzhen Ye, Huan Ma, Guofeng Qu, et al.
Inorganic Chemistry|August 19, 2025
Coordination Confinement on the Decay Chains of Typical Medical α-RadionuclidesLong Qiu, Shilong Shi, Linwei He, et al.
Molecular Pharmaceutics|August 22, 2022
Targeted Alpha Therapy of Glioma Using <sup>211</sup>At-Labeled Heterodimeric Peptide Targeting Both VEGFR and IntegrinsWeihao Liu, Huan Ma, Ranxi Liang, et al.
Biomaterials Research|September 8, 2022
Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progressionJiajia Zhang, Feize Li, Yuzhen Yin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2025
Preclinical evaluation of [<sup>211</sup>At]At-AuNP-ABDMPL16 for targeted alpha therapy in MelanomaJiajia Zhang, Shanshan Qin, Xuhao Huang, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Nuclear Medicine and Biology|March 4, 2019
A radiopharmaceutical [<sup>89</sup>Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivoYu Tang, Yingjiang Hu, Weihao Liu, et al.
Journal of Environmental Radioactivity|March 31, 2019
Sorption of selenite on Tamusu clay in simulated groundwater with high salinity under aerobic/anaerobic conditionsHanyi He, Jun Liu, Yang Dong, et al.
Theranostics|December 8, 2025
Emergence of a barium metal-organic framework for mitigating off-target effects of alpha radionuclide therapyLong Qiu, Jie Lyu, Yuqi Guo, et al.
Inorganic Chemistry|July 1, 2026
Molecular Insights into the Extraction and Stripping Mechanisms of UO<sub>2</sub><sup>2+</sup> and Th<sup>4+</sup> by the Externally α-Irradiated Tri-<i>iso</i>-pentyl PyrophosphateShilong Shi, Yaoshuang Wan, Guofeng Qu, et al.
Bioorganic & Medicinal Chemistry|November 8, 2023
Biocompatible conjugated polymer nanoparticles labeled with <sup>225</sup>Ac for tumor endoradiotherapyXijian Chen, Ranxi Liang, Weihao Liu, et al.
Molecular Pharmaceutics|August 20, 2025
Multivalent <sup>211</sup>At-Radiolabeled Fibroblast Activation Protein Inhibitors for Targeted Alpha-Therapy of GliomaTianzhen Ye, Huan Ma, Guofeng Qu, et al.
Inorganic Chemistry|August 19, 2025
Coordination Confinement on the Decay Chains of Typical Medical α-RadionuclidesLong Qiu, Shilong Shi, Linwei He, et al.
Molecular Pharmaceutics|August 22, 2022
Targeted Alpha Therapy of Glioma Using <sup>211</sup>At-Labeled Heterodimeric Peptide Targeting Both VEGFR and IntegrinsWeihao Liu, Huan Ma, Ranxi Liang, et al.
Biomaterials Research|September 8, 2022
Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progressionJiajia Zhang, Feize Li, Yuzhen Yin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2025
Preclinical evaluation of [<sup>211</sup>At]At-AuNP-ABDMPL16 for targeted alpha therapy in MelanomaJiajia Zhang, Shanshan Qin, Xuhao Huang, et al.
Pageof 9